Emily A. Rosen

565 citations
15 papers · 310 indexed · h-index 6
Topics
Ear Surgery and Otitis Media (4 papers)Hearing Loss and Rehabilitation (4 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)

In The Last Decade

Emily A. Rosen

12 papers receiving 309 citations

Peers

Emily A. Rosen
Comparison fields: 5 of 44
  • Genetics 230
  • Hematology 199
  • Molecular Biology 160
  • Rheumatology 63
  • Immunology 21
Replace Anna Ravn Landtblom with:
Anna Ravn Landtblom Sweden
Piera Sivera Italy
Ana Kerguelen Spain
Marianna De Muro Italy
Elina K. Cook Canada
Mariarita Sciumé Italy
Sidharth Totadri India
Nadja Jäkel Germany
J. Shan United States
Adriano Salaroli Italy
Emily A. Rosen relative to Anna Ravn Landtblom Sweden Anna Ravn Landtblom's profile →
Citations per field
00.5×2.6×
Anna Ravn Landtblom · 1×
Citations per year

Countries citing papers authored by Emily A. Rosen

Since Specialization
Citations

This map shows the geographic impact of Emily A. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Rosen more than expected).

Fields of papers citing papers by Emily A. Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Rosen. The network helps show where Emily A. Rosen may publish in the future.

Co-authorship network of co-authors of Emily A. Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Rosen. A scholar is included among the top collaborators of Emily A. Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Rosen. Emily A. Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 2
3 0
4 1
5 3
6 0
7 1
8
0
9 7
10 5
11 189
12 3
13 72
14 15
15 11

About Emily A. Rosen

Emily A. Rosen is a scholar working on Otorhinolaryngology, Applied Microbiology and Biotechnology and Genetics, having authored 15 papers that have together received 310 indexed citations. Recurring topics across this work include Ear Surgery and Otitis Media (4 papers), Hearing Loss and Rehabilitation (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (230 citations), Hematology (199 citations) and Applied Microbiology and Biotechnology (11 citations). Emily A. Rosen has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Edwin Chen, Ann Mullally, Rebekka K. Schneider, Shannon Elf, Amy Ko, Fátima Al‐Shahrour, Javier Perales-Patón, Ofir Wolach, Julie-Aurore Losman and Zuzana Tóthová. Their work appears in journals such as Blood, The Lancet Infectious Diseases and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026